Not available outside of the UK & Ireland.
Application
4-Hydroxymephenytoin has been used for developing ultra performance LC (UPLC)- tandem mass spectrometry (MS/MS) assays for evaluating cytochrome P450 (CYP) probe drugs and their relevant metabolites in human urine or plasma samples. 4-hydroxymephenytoin has also been used for developing sub-2-micron particle LC/MS/MS-based methods for analyzing CYP450 probe substrate metabolites.
Biochem/physiol Actions
4-Hydroxymephenytoin catabolism displays genetic polymorphism and is a direct indicator of Cytochrome P450 2C19 (CYP2C19) activity. Detection and quantification of 4-hydroxymephenytoin in biological samples by HPLC method is well optimized.
General description
CYP2C19 metabolite of mephenytoin.
Packaging
5, 10 mg in glass bottle
Bottomless glass bottle. Contents are inside inserted fused cone.
This product has met the following criteria to qualify for the following awards: